| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0022000 | Exon-Exon | chr10:31815896-31816045 | chr10:31526968-31527117 | 150 nt | 0.4400 |
| hsa_ZEB1_0022100 | Exon-Exon | chr10:31815907-31816088 | chr10:31526979-31527160 | 182 nt | 0.4451 |
| hsa_ZEB1_0022200 | Exon-Exon | chr10:31815912-31816088 | chr10:31526984-31527160 | 177 nt | 0.4407 |
| hsa_ZEB1_0022300 | Exon-Exon | chr10:31815944-31816088 | chr10:31527016-31527160 | 145 nt | 0.4414 |
| hsa_ZEB1_0022400 | Exon-Exon | chr10:31815947-31816088 | chr10:31527019-31527160 | 142 nt | 0.4366 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].